Stock screenerAll disclosures →
EDGAR →
ACON
Conviction 4HealthcareScan · Thu, Jun 25, 2026ACON$2.68-2.19%
ResistanceSupportVol 14Insider buy2
Vol MA14 96.97K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price2.68
Change-2.19%
Gap+0.00%
Rel volume1.19×
Avg volume128.04K
Avg $ vol400.91K
SMA 203.18
SMA 503.24
SMA 2004.86
Price vs 50-17.26%
Price vs 200-44.82%
MA stackbearish
50/200 cross—
Supertrenddown · 3.35
RSI (14)31
MACD hist-0.06
MACD cross—
Stoch %K / %D4 / 5
ADX (14)15
+DI / −DI19 / 29
RSI divergence—
MACD divergence—
ATR %+7.81%
ADR %6.63%
52w high9.69
52w low2.36
From 52w high-72.34%
Above 52w low+13.56%
New 52w highNo
SqueezeOff
Bollinger width30.83%
%B-0.01
Donchian pos4.11%
Donchian high3.61
Donchian low2.64
AVWAP (52w high)7.23
vs AVWAP high-62.93%
AVWAP (52w low)3.22
vs AVWAP low-16.82%
OBV trendUp
Chaikin MF (20)-0.27
Today vs 20d1.19×
Avg vol (14d)96.97K
Avg vol (20d)128.04K
Avg $ vol (20d)400.91K
Market cap6.6M
RS 3m (vs SPY)-32.84%
RS 6m (vs SPY)-63.54%
RS line new highNo
Trend template0/8
Technical rank7.4
1 week-13.83%
1 month-15.19%
3 months-17.03%
6 months-56.74%
1 year-60.59%
YTD-46.18%
P/E-0.91
P/B0.34
P/S87.14
P/FCF-0.92
EPS-13.61
Div yield—
ROE-36.80%
ROA-35.05%
Debt/Eq—
Current19.65
EV/EBITDA1.82
Gross margin9.02%
Net margin—
Rev growth65.62%
EPS growth-3.44%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value-12.41M
Revenue21.14K
Net income-2.85M
Gross profit3.75K
Free cash flow-7.19M
IndustrySERVICES-MEDICAL LABORATORIES
ExchangeNasdaq
Shares out2.46M
Employees11
ListedFri, Apr 22, 2022
Free float2.42M
Float %98.3%
Short interest180.13K
Days to cover1.5d
Short volume24.3%
Squeeze score25 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction4 / 100
Pattern quality—
Tech rank7.4 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance3.55
Support2.88
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ACON
No recent disclosed trades by Congress in ACON. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ACON · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Deitsch Stephen Director · Common Stock · 2026-06-11 | Grant | 20K | — | 2026-06-11 | 2026-06-12 |
Thramann Jeffrey John Executive Chairman · Common Stock · 2026-06-11 | Grant | 100K | — | 2026-06-11 | 2026-06-12 |
Neal David K Director · Common Stock · 2026-06-11 | Grant | 20K | — | 2026-06-11 | 2026-06-12 |
Wesemann William Director · Common Stock · 2026-06-11 | Grant | 20K | — | 2026-06-11 | 2026-06-12 |
Ness Brent Chief Executive Officer · Common Stock · 2026-06-11 | Grant | 100K | — | 2026-06-11 | 2026-06-12 |
Breidbart Scott Director · Common Stock · 2026-06-11 | Grant | 20K | — | 2026-06-11 | 2026-06-12 |
Gould Gregory A Chief Financial Officer · Common Stock · 2026-06-11 | Grant | 50K | — | 2026-06-11 | 2026-06-12 |
Sequira Amanda Mae Director · Common Stock · 2026-06-11 | Grant | 20K | — | 2026-06-11 | 2026-06-12 |
Bond Ryan Chief Strategy Officer · Common Stock · 2026-06-11 | Grant | 55K | — | 2026-06-11 | 2026-06-12 |
Breidbart Scott Director · Common Stock · 2026-05-12 | Buy | 5.66K | $18K | 2026-05-12 | 2026-05-12 |
SEC filings
EDGAR filings in ACON · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.